Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis.
Calderon-Espinosa E, De Ridder K, Benoot T, Jansen Y, Vanhonacker D, Heestermans R, De Becker A, Van Riet I, Decoster L, Goyvaerts C. Calderon-Espinosa E, et al. Among authors: de becker a. Front Immunol. 2024 Aug 1;15:1397469. doi: 10.3389/fimmu.2024.1397469. eCollection 2024. Front Immunol. 2024. PMID: 39148724 Free PMC article. Review.
Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives.
Heyrman B, Meers S, Sid S, Put N, Theunissen K, Van Eygen K, De Beule N, Clauwaert M, Maes H, Salembier A, Lemmens J, Velde AV, Selleslag D, Bouziotis J, De Becker A, Anguille S. Heyrman B, et al. Among authors: de becker a. EJHaem. 2024 Oct 4;5(5):1096-1099. doi: 10.1002/jha2.1027. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415916 Free PMC article. No abstract available.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Papanicolaou GA, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Fournier M, Murray RA, Wu J, Winston DJ; AURORA Trial Investigators. Papanicolaou GA, et al. Clin Infect Dis. 2024 Mar 20;78(3):562-572. doi: 10.1093/cid/ciad709. Clin Infect Dis. 2024. PMID: 38036487 Free PMC article. Clinical Trial.
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis.
Servais S, Baron F, Lechanteur C, Seidel L, Baudoux E, Briquet A, Selleslag D, Maertens J, Poire X, Schroyens W, Graux C, De Becker A, Zachee P, Ory A, Herman J, Kerre T, Beguin Y. Servais S, et al. Among authors: de becker a. Front Immunol. 2023 Feb 1;14:1106464. doi: 10.3389/fimmu.2023.1106464. eCollection 2023. Front Immunol. 2023. PMID: 36817464 Free PMC article.
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies.
Planken S, De Becker A, Kerre T, Schoemans H, Baron F, Graux C, Van Riet I, Lechanteur C, Baudoux E, Schots R, Beguin Y; Transplant Committee of the Belgian Hematology Society.. Planken S, et al. Among authors: de becker a. Curr Res Transl Med. 2024 Dec;72(4):103466. doi: 10.1016/j.retram.2024.103466. Epub 2024 Aug 17. Curr Res Transl Med. 2024. PMID: 39213720 Clinical Trial.
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.
Meeus F, Funeh CN, Awad RM, Zeven K, Autaers D, De Becker A, Van Riet I, Goyvaerts C, Tuyaerts S, Neyns B, Devoogdt N, De Vlaeminck Y, Breckpot K. Meeus F, et al. Among authors: de becker a. J Immunother Cancer. 2024 Nov 19;12(11):e009110. doi: 10.1136/jitc-2024-009110. J Immunother Cancer. 2024. PMID: 39562005 Free PMC article.
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
Vandewalle N, Satilmis H, Verheye E, Fan R, Wang Y, De Groof TWM, Bridoux J, Kerre T, De Beule N, De Becker A, De Bruyne E, Menu E, Vanderkerken K, Breckpot K, Devoogdt N, De Veirman K. Vandewalle N, et al. Among authors: de becker a. Theranostics. 2024 Apr 15;14(7):2656-2674. doi: 10.7150/thno.91456. eCollection 2024. Theranostics. 2024. PMID: 38773967 Free PMC article.
53 results